Consolidated Financial Statements
- Consolidated Statement of Financial Position
- Consolidated Statement of Profit or Loss
- Consolidated Statement of Cash Flows
Consolidated Statement of Cash Flows
(Millions of yen)
| 2016 | 2017 | 2018 | |
| Cash flows from (used in) operating activities | |||
| Profit before tax | 150,068 | 196,984 | 207,308 |
| Depreciation and amortization expenses | 71,131 | 101,813 | 109,206 |
| Impairment losses | 6,336 | 10,128 | 294 |
| Interest and dividend income | -2,836 | -2,975 | -3,115 |
| Interest expenses | 3,763 | 6,725 | 6,753 |
| Share of profit (loss) of entities accounted for using equity method | -1,974 | -1,055 | -887 |
| Gain on sales of investments accounted for using equity method | -12,163 | -17,898 | 901 |
| Gain (loss) on sales of stocks of subsidiaries and affiliates | － | -10,542 | － |
| Loss (gain) on sales and disposals of property, plant and equipment | -1,324 | 5,469 | 4,148 |
| Gain on remeasurements related to business combinations | － | － | － |
| Increase (decrease) in trade receivables | -9,821 | -11,536 | -2,759 |
| Increase (decrease) in inventories | -607 | -4,752 | -8,966 |
| Increase (decrease) in trade payables | 6,369 | 7,490 | -3,397 |
| Decrease (increase) in accrued alcohol tax | 497 | -3,834 | -3,799 |
| Increase (decrease) in net defined benefit assets and liabilities | -2,096 | 1,358 | 655 |
| Other | -2,623 | 32,304 | 52,319 |
| Subtotal | 204,718 | 309,680 | 358,664 |
| Interest and dividends received | 5,546 | 5,839 | 3,662 |
| Inrerest paid | -3,658 | -5,601 | -6,831 |
| Income taxes paid | -52,153 | -78,205 | -103,053 |
| Net cash flows from (used in) operating activities | 154,452 | 231,712 | 252,441 |
| Cash flows from (used in) investing activities | |||
| Purchase of property, plant and equipment | -50,357 | -76,636 | -78,891 |
| Proceeds from sales of property, plant and equipment | 11,923 | 2,315 | 2,027 |
| Purchase of intangible assets | -7,791 | -11,246 | -8,997 |
| Purchase of investment securities | -2,286 | -1,430 | -986 |
| Proceeds from sales of financial assets | 30,870 | 11,939 | 10,591 |
| Proceeds from sales of investment in an entity accounted for using equity method | 36,440 | 68,972 | 101,646 |
| Purchase of shares of subsidiaries and others resulting in change in scope of consolidation | -290,893 | -891,555 | － |
| Proceeds from sales of subsidiaries and others relating to the change of scope of consolidation | － | 15,318 | 989 |
| Other | 3,587 | -3,499 | -3,874 |
| Net cash flows from (used in) investing activities | -268,507 | -885,823 | 22,505 |
| Cash flows from (used in) financing activities | |||
| Increase (decrease) in short-term borrowings | -10,793 | 41,076 | -105,281 |
| Payments of finance lease liabilities | -10,765 | -9,851 | -9,087 |
| Proceeds from long-term borrowings | 205,310 | 303,378 | 2,566 |
| Repayments of long-term borrowings | -7,479 | -62,600 | -96,821 |
| Proceeds from issuance of bonds | － | 436,604 | － |
| Redemption of bonds | -30,000 | -18,000 | -20,000 |
| Purchase of treasury shares | -21 | -38 | -250 |
| Dividends paid | -23,817 | -26,571 | -41,229 |
| Proceeds from share issuance to non-controlling shareholders | 313 | 261 | 48 |
| Purchase of shares of subsidiaries not resulting in change in scope of consolidation | -2,773 | -39 | － |
| Other | -419 | -2,336 | -508 |
| Net cash flows from (used in) financing activities | 119,554 | 661,882 | -270,564 |
| Effect of exchange rate changes on cash and cash equivalents | 642 | 2,111 | -4,416 |
| Net increase (decrease) in cash and cash equivalents | 6,141 | 9,883 | -33 |
| Cash and cash equivalents at beginning of period | 43,290 | 48,459 | 58,054 |
| Increase (decrease) in cash and cash equivalents resulted from change in scope of consolidation | － | － | -703 |
| Cash and cash equivalents transferred to assets held for sale | -972 | -288 | － |
| Cash and cash equivalents at the end of period | 48,459 | 58,054 | 57,317 |
